Power of Attorney for Jialiang Wang

2026-05-07SEC Filing 3 (0001140361-26-019651)

This filing details a Power of Attorney granted by Jialiang Wang, EVP, General Manager at GYRE THERAPEUTICS, INC., to Ying Luo, Thomas Eastling, and Joshua Bergmann. The attorneys-in-fact are authorized to execute and submit SEC filings, including Forms 3, 4, and 5, and to obtain necessary electronic filing credentials. The power of attorney remains effective until Mr. Wang is no longer required to file such forms or until earlier revoked. The filing also lists several stock options held by Mr. Wang, with exercise prices ranging from $0.32 to $5.98 and expiration dates spanning from 2028 to 2034. Specific details regarding vesting schedules and underlying security shares are provided for these options.

Ticker mentioned:GYRE